Intellectual property (IP) challenges for U.S. corporations can take many forms. Sometimes that can mean failing to recognize the threat of a cyber breach. At other times, that can mean ignoring ...

Selin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should ...

The world of legal technology is increasingly becoming a battleground for intellectual property (IP) rights, where innovation meets the rigid constructs of law. In this dynamic environment, ...

University tech transfer programmes are not like typical intellectual property departments in private companies. For one, inventors can choose whether they want to commercialise a breakthrough ...

In this series' last installment, I tackled the IP lessons learned in traditional startups. Here, I explore IP paint points experienced by some non-traditional companies, such as non-profit, non-tech, ...

In November, the UIC John Marshall Law School held their 63rd Annual Intellectual Property Conference in Chicago, IL. The program consisted of four plenary sessions and nine breakout sessions covering ...

This is an Insight article, written by a selected contributor as part of WTR's co-published content. Read more on Insight In China, there is no US-style discovery procedure, and the burden of proof is ...

On April 10, 2025, Italian fashion house Prada announced its acquisition of Versace from Capri Holdings for $1.375 billion, uniting two of Italy’s most iconic luxury brands. Though financial ...

“Following the takeover by SoftBank, the valuation of WeWork has dropped almost overnight from over $47 billion to $8 billion (as of the writing of this article). Since the fundamentals of the company ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week. Our brand new Special Report reveals ...

Hear from the FDA and the leaders of the biosimilars and innovator biologics industries about the impact of the pandemic on the global IP market and gain practical guidance for what is coming down the ...